HER2-low Status and Response to Neoadjuvant Chemotherapy in HER2 Negative Early Breast Cancer.
Breast Cancer Research and Treatment(2021)
Key words
HER2,HER2-low breast cancer,Antibody–drug conjugates,Trastuzumab–deruxtecan,Trastuzumab–duocarmazine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined